TriangleHEALTH PROFESSIONAL · SOURCE READING
Interferon alfa-2b
Source: Kaposi Sarcoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: May 7, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
The FDA approved interferon alfa-2b for the treatment of AIDS-associated KS. It is sometimes used off-label for classic KS.
Evidence (interferon alfa-2b):
A small case series included 16 patients without HIV.[25]
Source links and citations
A small case series included 16 patients without HIV.[25]
Treatment with interferon alfa-2b led to a response in ten patients (one complete response [CR], nine partial responses [PRs]).
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice